PATENT CLAIM ANALYSIS

Application Number: 15746590
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["424", "133100"]

Abstract:
The present invention relates to humanized antibodies that specifically bind to human transferrin receptor and their use in treating cancer and inflammatory disorders.

Claim (Index 13):
A cloning or expression vector according to  claim 12 , comprising at least one of the nucleic acids encoding a heavy chain of SEQ ID NO: 18 and a light chain of SEQ ID NO: 17.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.09091
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14116714', '14283038', '13916379', '14441307', '14958053']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7003279412845868
- 35 USC 102 Novelty (BERT): 0.5320014527788208
- Combined Prediction Score: 0.6834952924340102
- Mean Citation Score: 324.06234
- Max Citation Score: 333.03397
- Similarity Product: 207.10071218414905

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test